GenesisX offers the benefits of robotic magnetic navigation while making the technology more accessible, Stereotaxis said.

Stereotaxis announced the first order for its GenesisX endovascular surgical robotics system utilizing robotic magnetic navigation.

Stereotaxis announced that physicians at Oulu University Hospital in Finland have successfully treated patients using its advanced Genesis Robotic Magnetic Navigation (RMN) System. This marks a ...

ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has ...

Stereotaxis has won European CE mark approval for its MaGiC ablation catheter, a robotically navigated device for the ...

TD Cowen analyst Josh Jennings maintained a Buy rating on Stereotaxis (STXS – Research Report) yesterday and set a price target of $5.00. The ...

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary ...

China's National Medical Products Administration (NMPA) has granted regulatory approval to the ‘Magbot Magnetic Navigation ... in unison with Stereotaxis' robotic systems, notably the Genesis ...

Stereotaxis’ MAGiC ablation catheter receives European CE Mark approval: St. Louis Tuesday, January 28, 2025, 16:00 Hrs [IST] Stereotaxis, a pioneer and global leader in surgica ...

P Stereotaxis ( (STXS ... treated the first patients using the advanced Genesis Robotic Magnetic Navigation (RMN) System from Stereotaxis. The health system is renowned for diagnosing and ...

14, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Oulu ...